You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Ginkgo biloba for intermittent claudication
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2013
|
| DOI | 10.1002/14651858.cd006888.pub3 |
| Pubmed ID | |
| Authors |
Saskia PA Nicolaï, Lotte M Kruidenier, Bianca LW Bendermacher, Martin H Prins, Rutger A Stokmans, Pieter PHL Broos, Joep AW Teijink |
| Abstract |
People with intermittent claudication (IC) suffer from pain in the muscles of the leg occurring during exercise which is relieved by a short period of rest. Symptomatic relief can be achieved by (supervised) exercise therapy and pharmacological treatments. Ginkgo biloba is a vasoactive agent and is used to treat IC. |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 4 | 36% |
| Colombia | 1 | 9% |
| Chile | 1 | 9% |
| Unknown | 5 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 73% |
| Practitioners (doctors, other healthcare professionals) | 3 | 27% |
Mendeley readers
The data shown below were compiled from readership statistics for 177 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Iran, Islamic Republic of | 1 | <1% |
| Korea, Republic of | 1 | <1% |
| Romania | 1 | <1% |
| Unknown | 174 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 29 | 16% |
| Student > Bachelor | 24 | 14% |
| Student > Master | 20 | 11% |
| Student > Ph. D. Student | 17 | 10% |
| Student > Doctoral Student | 9 | 5% |
| Other | 25 | 14% |
| Unknown | 53 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 62 | 35% |
| Nursing and Health Professions | 14 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
| Agricultural and Biological Sciences | 9 | 5% |
| Biochemistry, Genetics and Molecular Biology | 5 | 3% |
| Other | 23 | 13% |
| Unknown | 55 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 September 2022.
All research outputs
#1,499,233
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#3,206
of 11,842 outputs
Outputs of similar age
#12,348
of 210,066 outputs
Outputs of similar age from Cochrane database of systematic reviews
#73
of 294 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,066 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 294 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.